These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7302925)

  • 41. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
    Gurrieri MA
    Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and primary structures of duck fibrinopeptides A and B.
    Yuan M; Zhu P; Zhang YS
    Sci Sin B; 1985 Jan; 28(1):31-5. PubMed ID: 3983613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats.
    Ruhenstroth-Bauer G; Scherer R; Hornberger M; Tongendorff G
    Inflammation; 1981 Dec; 5(4):343-51. PubMed ID: 7327698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of desulphated bovine fibrinopeptide B and demonstration of its sulphation in vitro by an enzyme system from neuroblastoma-glioma hybrid cells.
    Barling PM; Palmer DJ; Christie DL
    Int J Biochem; 1986; 18(2):137-41. PubMed ID: 3456327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
    Soya K; Takezawa Y; Terasawa F; Okumura N
    Rinsho Byori; 2012 Jun; 60(6):499-505. PubMed ID: 22880226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibrinogen and the early stages of polymerization to fibrin as studied by dynamic laser light scattering.
    Larsson U; Blombäck B; Rigler R
    Biochim Biophys Acta; 1987 Sep; 915(2):172-9. PubMed ID: 3651470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels.
    Kodama M; Naito M; Nomura H; Iguchi A; Thompson WD; Stirk CM; Smith EB
    Life Sci; 2002 Jul; 71(10):1139-48. PubMed ID: 12095535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.